Inogen Inc (INGN) › Cash & EquivalentsInogen Inc (INGN) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2011: $3.91M2012: $15.11M2013: $13.52M2014: $56.84M2015: $66.11M2016: $92.85M2017: $142.95M2018: $196.63M2019: $198.04M2020: $211.96M2021: $235.52M2022: $187.01M2023: $125.49M2024: $113.80M2025: $103.73M$103.73M2011Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$103.73M-8.8%2024$113.80M-9.3%2023$125.49M-32.9%2022$187.01M-20.6%2021$235.52M+11.1%2020$211.96M+7.0%2019$198.04M+0.7%2018$196.63M+37.6%2017$142.95M+54.0%2016$92.85M+40.5%2015$66.11M+16.3%2014$56.84M+320.4%2013$13.52M-10.5%2012$15.11M+286.9%2011$3.91M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share